Twenty-four month follow-up of tocilizumab therapy for refractory uveitis-related macular edema

Conclusion: In this long-term study, TCZ was effective and had a comparable safety profile to published data for TCZ use in other indications, when used for the treatment of refractory uveitis-related ME.
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research